12,940 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Purchased by Cozad Asset Management Inc.

Cozad Asset Management Inc. bought a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the 3rd quarter, HoldingsChannel reports. The firm bought 12,940 shares of the pharmacy operator’s stock, valued at approximately $116,000.

Other large investors also recently made changes to their positions in the company. Centennial Wealth Advisory LLC increased its stake in Walgreens Boots Alliance by 24.2% in the 3rd quarter. Centennial Wealth Advisory LLC now owns 17,113 shares of the pharmacy operator’s stock valued at $153,000 after buying an additional 3,337 shares during the period. NorthRock Partners LLC acquired a new position in shares of Walgreens Boots Alliance in the third quarter worth $97,000. Sentry Investment Management LLC acquired a new position in shares of Walgreens Boots Alliance in the third quarter worth $30,000. QRG Capital Management Inc. raised its holdings in shares of Walgreens Boots Alliance by 85.9% during the third quarter. QRG Capital Management Inc. now owns 31,706 shares of the pharmacy operator’s stock worth $284,000 after acquiring an additional 14,651 shares in the last quarter. Finally, Asset Management One Co. Ltd. boosted its position in Walgreens Boots Alliance by 9.2% during the third quarter. Asset Management One Co. Ltd. now owns 393,500 shares of the pharmacy operator’s stock valued at $3,526,000 after purchasing an additional 33,253 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

NASDAQ WBA opened at $9.07 on Friday. The stock has a 50-day simple moving average of $9.18 and a 200 day simple moving average of $12.21. Walgreens Boots Alliance, Inc. has a twelve month low of $8.22 and a twelve month high of $27.05. The stock has a market capitalization of $7.84 billion, a PE ratio of -0.91, a P/E/G ratio of 1.21 and a beta of 0.69. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company had revenue of $37.50 billion during the quarter, compared to analysts’ expectations of $35.75 billion. During the same period in the prior year, the business earned $0.67 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 5.9% compared to the same quarter last year. Research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be issued a dividend of $0.25 per share. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 annualized dividend and a dividend yield of 11.03%. Walgreens Boots Alliance’s payout ratio is -9.99%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on WBA shares. UBS Group upped their target price on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday, October 17th. Barclays boosted their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 16th. JPMorgan Chase & Co. cut their price target on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a report on Friday, August 30th. Truist Financial decreased their price objective on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a report on Monday, October 7th. Finally, Bank of America cut their target price on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a report on Wednesday, September 4th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $12.88.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.